Search by Drug Name or NDC

    NDC 00006-0277-14 JANUVIA 100 mg/1 Details

    JANUVIA 100 mg/1

    JANUVIA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is SITAGLIPTIN PHOSPHATE.

    Product Information

    NDC 00006-0277
    Product ID 0006-0277_6970c5e9-bd40-4847-9321-ab5826b7b7e5
    Associated GPIs 27550070100340
    GCN Sequence Number 061614
    GCN Sequence Number Description sitagliptin phosphate TABLET 100 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 97400
    HICL Sequence Number 034126
    HICL Sequence Number Description SITAGLIPTIN PHOSPHATE
    Brand/Generic Brand
    Proprietary Name JANUVIA
    Proprietary Name Suffix n/a
    Non-Proprietary Name sitagliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name SITAGLIPTIN PHOSPHATE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021995
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-0277-14 (00006027714)

    NDC Package Code 0006-0277-14
    Billing NDC 00006027714
    Package 2 BLISTER PACK in 1 CARTON (0006-0277-14) / 7 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2012-10-12
    NDC Exclude Flag N
    Pricing Information N/A